Select Ongoing Trials Currently Enrolling Patients with Gynecologic Cancers.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 28
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 2
Results: 15
1
2
Xalkori Approved for Pediatric Patients and Young Adults with Relapsed or Refractory ALK-Positive ALCL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 27
- Publication type:
- Article
3
FDA Approves Opdivo plus Cabometyx Combination for Advanced Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 26
- Publication type:
- Article
4
Tepmetko Approved for Patients with NSCLC and MET Exon 14 Skipping Alterations.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 26
- Publication type:
- Article
5
First-Line Combinations Show Promise in the Treatment of Patients with Advanced Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 24
- By:
- Publication type:
- Article
6
Targeting HIF-2 Has the Potential to Improve Outcomes for Patients with Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 22
- By:
- Publication type:
- Article
7
Spotlight on Epic Care: Empowerment and Excellence Through Education.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 20
- By:
- Publication type:
- Article
8
Strategies for Increasing Representation of Minorities in Clinical Trials.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 19
- Publication type:
- Article
9
Vodobatinib Effective in Patients with CML Regardless of Previous Ponatinib Therapy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 17
- By:
- Publication type:
- Article
10
Promising Results Seen with Ruxolitinib as Second-Line Treatment for Chronic GVHD.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 16
- By:
- Publication type:
- Article
11
Belantamab Induces Clinically Meaningful Responses in Heavily Pretreated Patients with Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 14
- By:
- Publication type:
- Article
12
Intervention Improves Quality of Life for Patients Experiencing Financial Toxicity.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 13
- By:
- Publication type:
- Article
13
Gathering and Assessing Social Determinants of Health for Improved Patient Outcomes.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
14
The Case for a Culture of Cybersecurity.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
15
Keeping a Watchful Eye in 2021.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article